OraSure Technologies Total Assets 2010-2025 | OSUR

OraSure Technologies total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
OraSure Technologies Annual Total Assets
(Millions of US $)
2024 $480
2023 $483
2022 $444
2021 $461
2020 $454
2019 $349
2018 $316
2017 $296
2016 $208
2015 $189
2014 $190
2013 $184
2012 $191
2011 $128
2010 $123
2009 $127
OraSure Technologies Quarterly Total Assets
(Millions of US $)
2025-03-31 $458
2024-12-31 $480
2024-09-30 $464
2024-06-30 $466
2024-03-31 $468
2023-12-31 $483
2023-09-30 $458
2023-06-30 $454
2023-03-31 $459
2022-12-31 $444
2022-09-30 $432
2022-06-30 $429
2022-03-31 $436
2021-12-31 $461
2021-09-30 $456
2021-06-30 $465
2021-03-31 $456
2020-12-31 $454
2020-09-30 $436
2020-06-30 $421
2020-03-31 $325
2019-12-31 $349
2019-09-30 $339
2019-06-30 $327
2019-03-31 $319
2018-12-31 $316
2018-09-30 $304
2018-06-30 $292
2018-03-31 $286
2017-12-31 $296
2017-09-30 $282
2017-06-30 $258
2017-03-31 $233
2016-12-31 $208
2016-09-30 $204
2016-06-30 $200
2016-03-31 $188
2015-12-31 $189
2015-09-30 $194
2015-06-30 $180
2015-03-31 $178
2014-12-31 $190
2014-09-30 $191
2014-06-30 $180
2014-03-31 $174
2013-12-31 $184
2013-09-30 $178
2013-06-30 $174
2013-03-31 $182
2012-12-31 $191
2012-09-30 $197
2012-06-30 $125
2012-03-31 $125
2011-12-31 $128
2011-09-30 $123
2011-06-30 $121
2011-03-31 $119
2010-12-31 $123
2010-09-30 $122
2010-06-30 $124
2010-03-31 $121
2009-12-31 $127
2009-09-30 $128
2009-06-30 $122
2009-03-31 $127
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.239B $0.186B
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.206B 27.56
Boston Scientific (BSX) United States $152.664B 38.22
Stryker (SYK) United States $149.191B 31.19
EssilorLuxottica (ESLOY) France $131.913B 0.00
Medtronic (MDT) Ireland $115.147B 16.32
Lonza Group Ag (LZAGY) Switzerland $50.094B 0.00
Haleon (HLN) United Kingdom $43.531B 24.85
ResMed (RMD) United States $37.280B 28.00
GE HealthCare Technologies (GEHC) United States $34.547B 16.40
Agilent Technologies (A) United States $32.221B 21.01
Terumo (TRUMY) Japan $24.355B 31.64
Koninklijke Philips (PHG) Netherlands $23.476B 16.47
Insulet (PODD) United States $20.287B 79.63
Zimmer Biomet Holdings (ZBH) United States $18.641B 11.97
Baxter (BAX) United States $14.559B 10.87
Smith & Nephew SNATS (SNN) United Kingdom $12.951B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.729B 23.42
Lantheus Holdings (LNTH) United States $5.148B 12.99
Perrigo (PRGO) Ireland $3.724B 9.44
Prestige Consumer Healthcare (PBH) United States $3.715B 16.59
Haemonetics (HAE) United States $3.575B 16.28
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.342B 27.77
ICU Medical (ICUI) United States $3.072B 22.66
LeMaitre Vascular (LMAT) United States $1.867B 41.72
QuidelOrtho (QDEL) United States $1.864B 12.82
AtriCure (ATRC) United States $1.504B 0.00
Acuren (TIC) United States $1.431B 0.00
Phibro Animal Health (PAHC) United States $1.238B 15.82
AdaptHealth (AHCO) United States $1.232B 12.51
Green Thumb Industries (GTBIF) United States $1.212B 27.26
Neogen (NEOG) United States $1.068B 13.67
BioLife Solutions (BLFS) United States $1.006B 0.00
InMode (INMD) Israel $0.901B 9.08
Kestra Medical Technologies (KMTS) United States $0.788B 0.00
Curaleaf Holdings (CURLF) Canada $0.670B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.642B 0.00
Owens & Minor (OMI) United States $0.613B 5.08
Tilray Brands (TLRY) Canada $0.607B 0.00
Evolus (EOLS) United States $0.593B 0.00
CeriBell (CBLL) United States $0.571B 0.00
Valneva SE (VALN) France $0.552B 0.00
Surmodics (SRDX) United States $0.446B 0.00
SNDL (SNDL) Canada $0.392B 0.00
Capricor Therapeutics (CAPR) United States $0.331B 0.00
VAREX IMAGING (VREX) United States $0.321B 11.82
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Sanuwave Health (SNWV) United States $0.300B 0.00
Quanterix (QTRX) United States $0.283B 0.00
Cerus (CERS) United States $0.270B 0.00
Viemed Healthcare (VMD) United States $0.264B 22.30
Cresco Labs (CRLBF) United States $0.260B 0.00
Aurora Cannabis (ACB) Canada $0.252B 74.67
Sanara MedTech (SMTI) United States $0.248B 0.00
ZimVie (ZIMV) United States $0.243B 11.04
Brainsway (BWAY) Israel $0.230B 60.75
Biote (BTMD) United States $0.224B 6.31
Omeros (OMER) United States $0.206B 0.00
Canopy Growth (CGC) Canada $0.202B 0.00
Verano Holdings (VRNOF) United States $0.200B 0.00
High Tide (HITI) Canada $0.197B 0.00
Organigram Global (OGI) Canada $0.196B 0.00
Utah Medical Products (UTMD) United States $0.183B 14.87
TriSalus Life Sciences (TLSI) United States $0.178B 0.00
Vireo Growth (VREOF) United States $0.152B 0.00
Exagen (XGN) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.123B 15.16
TerrAscend (TSNDF) Canada $0.101B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.100B 12.87
MacroGenics (MGNX) United States $0.096B 0.00
Quipt Home Medical (QIPT) United States $0.090B 0.00
Veru (VERU) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
Apyx Medical (APYX) United States $0.079B 0.00
Jushi Holdings (JUSHF) United States $0.075B 0.00
Zynex (ZYXI) United States $0.069B 0.00
InterCure (INCR) Israel $0.068B 0.00
Agape ATP (ATPC) $0.068B 0.00
Cytosorbents (CTSO) United States $0.065B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
United-Guardian (UG) United States $0.043B 14.76
Modular Medical (MODD) United States $0.038B 0.00
Safety Shot (SHOT) United States $0.037B 0.00
Nephros (NEPH) United States $0.037B 49.29
Rockwell Medical (RMTI) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.015B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
IM Cannabis (IMCC) Canada $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00